Literature DB >> 2935910

Mechanism of regulation of immune responses by in vivo administration of monoclonal anti-I-A antibodies.

M I Greene, L Perry, A Carroll, A Lowy.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2935910     DOI： 10.1007/bf02918670

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN： 0252-9564


× No keyword cloud information.
  19 in total

1.  Genetic control of the immune response to myoglobins. IV. Inhibition of determinant-specific Ir gene-controlled antigen presentation and induction of suppression by pretreatment of presenting cells with anti-Ia antibodies.

Authors:  J A Berzofsky; L K Richman
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

2.  Epidermal antigen-presenting cells in activation of suppression: identification of a new functional type of ultraviolet radiation-resistant epidermal cell.

Authors:  R D Granstein; A Lowy; M I Greene
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

3.  Mechanisms of regulation of cell-mediated immunity: anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo.

Authors:  L L Perry; M E Dorf; B A Bach; B Benacerraf; M I Greene
Journal:  Clin Immunol Immunopathol       Date:  1980-03

4.  In vivo administration of anti-I-A antibody induces the internalization of B cell surface I-A and I-E without affecting the expression of surface immunoglobulin.

Authors:  M Fultz; F D Finkelman; J J Mond
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.

Authors:  L L Perry; M E Dorf; B Benacerraf; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

6.  Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies.

Authors:  M K Waldor; R R Hardy; K Hayakawa; L Steinman; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.

Authors:  M I Greene; M E Dorf; M Pierres; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30).

Authors:  S Broder; D L Mann; T A Waldmann
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

9.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells.

Authors:  A M Kruisbeek; M J Fultz; S O Sharrow; A Singer; J J Mond
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307
View more
  1 in total

1.  Anti-I-A antibody modulation of lymphocyte traffic in hapten-stimulated inbred mice.

Authors:  A M Carroll; M I Greene
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.